Xeris Biopharma Holdings, Inc. (XERS) - Stock Prices, Stock Peers & Analysis

Home
XERS

Company Name	Xeris Biopharma Holdings, Inc.
Symbol	XERS
Currency	USD
Price	3.22
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	479,776,780
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	1.46 - 3.39
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Paul R. Edick
Website	https://www.xerispharma.com

An error occurred while fetching data.

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary